Exact Sciences

Exact Sciences Corporation, headquartered in Madison, Wisconsin, specializes in cancer screening and diagnostic tests, both in the United States and internationally. The company is best known for Cologuard, a non-invasive stool-based DNA test designed to detect colorectal cancer and pre-cancer. Additionally, Exact Sciences offers Oncotype DX, a suite of gene expression tests that assess recurrence risk and chemotherapy benefits for breast, prostate, and colon cancers. The company is actively developing liquid biopsy tests aimed at improving cancer detection and monitoring, including tests for molecular residual disease and additional cancers. Exact Sciences holds exclusive intellectual property for its screening technology, which is recognized in the colorectal cancer screening guidelines of leading medical organizations.